| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |